Science and Innovation at Cancer Research UK

Show us the beauty of your research today! 📸 Our inaugural photo campaign is now open for entries. We want images of your science to get featured across our channels – find out more and how to get involved: news.cancerresearchuk.org/2024/04/29/sho… #ResearchIsBeautiful

🌟 Our #ResearchIsBeautiful campaign continues to inspire! Congratulations to Danny Gold from the University of Oxford for his stunning image which captures microtubules attaching to chromosomes via kinetochores to form mitotic spindles. Hear more from…

Yoryos Lyratzopoulos & Matthew Barclay received a Project Award to assess whether optimal #lungcancer treatment is consistent across geographical locations and if treatment variation impacts survival. Find out more: cruk.org/PRCproject #CRUKFunded @MattBarclay89 | @ucl

[3/3] Bernard Rachet & Ellen Nolte will evaluate how multiple sociodemographic factors interact leading to inequalities in cancer care & outcomes across England and propose strategies to reduce the impact of these inequalities. #CRUKFunded @LSHTM

[2/3] Ruth Langley & John Burn will investigate platelet activation suppression by aspirin & its effect on tumour immunogenicity to expand understanding of anticancer mechanisms and validate urinary 11-dehydro-TXB2 as a biomarker for aspirin responders. #CRUKFunded @ruthjlangley…

[1/3] Excited to announce the incredible researchers selected by our Prevention and Population Research Committee for Programme Awards 🎉 Read on to learn about their projects and find out more about the scheme: cruk.org/PRCprogramme

[4/4] Andrew Gilmore, Sacha Howell, Susan Astley Theodossiadis & Sankari Nagarajan will identify mammographic and genetic markers of response to preventive tamoxifen in #breastcancer to inform novel prevention strategies for resistant patients. #CRUKFunded @OfficialUoM

[3/4] Rebecca Fitzgerald & John Lizhe Zhuang will uncover mechanisms of proliferation in hereditary diffuse #gastriccancer to identify therapeutic targets & reduce life-altering gastrectomies. #CRUKFunded @RFitzgerald_lab | @RC_Fitzgerald | @johnlzhuang | @Cambridge_Uni

[2/4] Karin Hellner gained a Biology to Prevention Award to develop and test the immunogenicity of an mRNA vaccine against all oncogenic human papillomaviruses to treat persisting infections in patients undergoing resection for #cervicalcancer. #CRUKFunded @UniofOxford

[1/4] 🧵 Introducing the latest researchers granted our Biology to Prevention Award by our Prevention and Population Research Committee 👇 Learn more about their research & find out about the scheme here: cruk.org/PRCbiology

We had too many to choose from in last month’s round of #ResearchIsBeautiful entries, so here’s a roundup of the ones that came out best of the rest!🔗bit.ly/41T021H Don’t forget - there’s just one day left to submit for the March round. We want to see anything that…

We spoke with Sally George from @ICR_London about the Stratified Medicine Paediatrics 2 study & their recent publication in @CD_AACR. The team’s research showed how ctDNA sequencing provides crucial insights into tumour evolution in young cancer patients. 🔗 Read more from…

[1/5] Getting the right data at the right time is essential for researchers looking to beat cancer sooner. Using advanced data modelling and AI, the CD3 programme is a £10m commitment to better understanding cancer.🔬 However to deliver on its promise Government must:

🚨 Abstract submissions for #PrevConf25 close today! Don't miss this chance to present your prevention research to a global audience at the Cancer Prevention Research Conference this summer. Submit abstract: bit.ly/4h8H64z @AmericanCancer | @theNCI

This series spotlights various topics related to equity, diversity and inclusivity in cancer research. The next seminar focuses on our communities, and how researchers can work effectively with public contributors to achieve excellent research outcomes Join the webinar 👇

#ICYMI: Researchers Richard Mair & Juanita Lopez are bringing new hope to people affected by #Glioblastoma. The 5G trial is a first-of-its-kind precision adaptive platform trial testing existing therapies proven safe and effective in other cancers. 🌟 Read more about 5G:…

Are you a cancer prevention researcher uncovering new insights in the field? Share your work with a global audience at #PrevConf25. 🚨 Submit your abstract by 21 March. Submit abstract: bit.ly/4h8H64z @AmericanCancer | @theNCI

[3/3] Andrew Clamp received an endorsement for the phase 3 SALVOVAR trial to assess if weekly dose-dense chemotherapy improves survival in a specific subpopulation of advanced #ovariancancer patients with poorly chemosensitive disease. @ucl

[2/3] Christopher Fox received an endorsement for the phase 2 RADICAL trial using four novel prognostic tools to identify patients with high-risk large B-cell #lymphoma & evaluating outcomes of adding epcoritamab to standard chemo-immunotherapy. @ProfChrisPFox | @UHSFT

[1/3] 🧵 The Clinical Research Committee endorses academically led, industry-sponsored clinical trials, allowing them to access research support. Follow along to hear about our most recent recipients 👇 Explore our Clinical Research Committee: bit.ly/3FiietN